These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8690817)

  • 1. Effect of food on the relative bioavailability of oral ganciclovir.
    Lavelle J; Follansbee S; Trapnell CB; Buhles WC; Griffy KG; Jung D; Dorr A; Connor J
    J Clin Pharmacol; 1996 Mar; 36(3):238-41. PubMed ID: 8690817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus- and cytomegalovirus-seropositive patients.
    Anderson RD; Griffy KG; Jung D; Dorr A; Hulse JD; Smith RB
    Clin Ther; 1995; 17(3):425-32. PubMed ID: 7585846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of food on high-dose oral ganciclovir disposition in HIV-positive subjects.
    Jung D; Griffy K; Dorr A
    J Clin Pharmacol; 1999 Feb; 39(2):161-5. PubMed ID: 11563408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral ganciclovir systemic exposure is enhanced in HIV-infected patients with diarrhea and weight loss.
    Mouly S; Aymard G; Diquet B; Caulin C; Bergmann JF
    J Acquir Immune Defic Syndr; 2000 Aug; 24(4):344-51. PubMed ID: 11015151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of oral ganciclovir alone and in combination with zidovudine, didanosine, and probenecid in HIV-infected subjects.
    Cimoch PJ; Lavelle J; Pollard R; Griffy KG; Wong R; Tarnowski TL; Casserella S; Jung D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Mar; 17(3):227-34. PubMed ID: 9495222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state relative bioavailability of three oral ganciclovir dosage regimens delivering 6,000 mg/day in patients with human immunodeficiency virus.
    Jung D; Griffy K; Wong R; Colburn W; Hulse J
    J Clin Pharmacol; 1998 Nov; 38(11):1021-4. PubMed ID: 9824783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers.
    Brown F; Banken L; Saywell K; Arum I
    Clin Pharmacokinet; 1999 Aug; 37(2):167-76. PubMed ID: 10496303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability and dose proportionality of oral ganciclovir after ascending multiple doses in human immunodeficiency virus (HIV)-positive patients.
    Jung D; Griffy K; Wong R; Colburn W; Hulse J
    J Clin Pharmacol; 1998 Dec; 38(12):1122-8. PubMed ID: 11301564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of high-dose oral ganciclovir on didanosine disposition in human immunodeficiency virus (HIV)-positive patients.
    Jung D; Griffy K; Dorr A; Raschke R; Tarnowski TL; Hulse J; Kates RE
    J Clin Pharmacol; 1998 Nov; 38(11):1057-62. PubMed ID: 9824788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral ganciclovir capsules in HIV-infected persons.
    Griffy KG
    AIDS; 1996 Dec; 10 Suppl 4():S3-6. PubMed ID: 9110063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects.
    Jung D; Dorr A
    J Clin Pharmacol; 1999 Aug; 39(8):800-4. PubMed ID: 10434231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of valganciclovir and ganciclovir in renal impairment.
    Czock D; Scholle C; Rasche FM; Schaarschmidt D; Keller F
    Clin Pharmacol Ther; 2002 Aug; 72(2):142-50. PubMed ID: 12189361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome--a population pharmacokinetic study.
    Mouly S; Aymard G; Tillement JP; Caulin C; Bergmann JF; Urien S
    Br J Clin Pharmacol; 2001 Jun; 51(6):557-65. PubMed ID: 11422015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function.
    Pescovitz MD; Pruett TL; Gonwa T; Brook B; McGory R; Wicker K; Griffy K; Robinson CA; Jung D
    Transplantation; 1998 Oct; 66(8):1104-7. PubMed ID: 9808499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Food-Effect Study to Evaluate the Oral Bioavailability of Desidustat.
    Patel H; Momin T; Kansagra K; Patel H; Shah C; Barot A; Bhavsar J; Zala K; Parmar D
    Clin Pharmacol Drug Dev; 2023 Apr; 12(4):356-362. PubMed ID: 36458679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics and safety profile of oral ganciclovir combined with zalcitabine or stavudine in asymptomatic HIV- and CMV-seropositive patients.
    Jung D; AbdelHameed MH; Teitelbaum P; Dorr A; Griffy K
    J Clin Pharmacol; 1999 May; 39(5):505-12. PubMed ID: 10234599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. AIDS Clinical Trials Group, and Cytomegalovirus Cooperative Study Group.
    Spector SA; Busch DF; Follansbee S; Squires K; Lalezari JP; Jacobson MA; Connor JD; Jung D; Shadman A; Mastre B
    J Infect Dis; 1995 Jun; 171(6):1431-7. PubMed ID: 7769276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food effect on the pharmacokinetics of entecavir from dispersible tablets following oral administration in healthy Chinese volunteers.
    Zhang QH; Yang J; He Y; Liu F; Wang JP; Davey AK
    Arzneimittelforschung; 2010; 60(10):640-4. PubMed ID: 21125816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral valganciclovir in children: single dose pharmacokinetics in a six-year-old girl.
    Burri M; Wiltshire H; Kahlert C; Wouters G; Rudin C
    Pediatr Infect Dis J; 2004 Mar; 23(3):263-6. PubMed ID: 15014306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.